Potential benefits of vitamin D for patients with systemic lupus erythematosus

Dermato-Endocrinology

Volumn 4, Issue 2, 2012, Pages 146-151

  Singh, Abha ^a   Kamen, Diane L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Autoimmune disease; Review; Systemic lupus erythematosus; Vitamin D

Indexed keywords

ALPHA INTERFERON; CALCITRIOL; COLECALCIFEROL; DOUBLE STRANDED DNA ANTIBODY; ERGOCALCIFEROL; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

AFRICAN AMERICAN; ANTIBODY PRODUCTION; ARTERIAL STIFFNESS; B LYMPHOCYTE; CARDIOVASCULAR DISEASE; CAUCASIAN; CELL DIFFERENTIATION; CELLULAR IMMUNITY; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOWN REGULATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; FRAGILITY FRACTURE; HIGH RISK POPULATION; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; OSTEOPOROSIS; PATHOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); RACE DIFFERENCE; REGULATORY T LYMPHOCYTE; REVIEW; SUN EXPOSURE; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; UPREGULATION; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 84865155976     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.20443     Document Type: Review

References (65)

1. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010; 9:709-15; PMID: 20601202; http://dx.doi.org/10.1016/j.autrev.2010.06.009
2. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl) 2010; 88:441-50; PMID:20119827; http://dx.doi.org/10.1007/s00109-010-0590-9
3. Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 2011; 58:186-92; PMID:21718915; http://dx.doi.org/10.1016/j.jacc.2011.02.051
4. Zhao G, Ford ES, Li C, Croft JB. Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens 2012; 30:284-9; PMID:22179077; http://dx.doi.org/10.1097/HJH.0b013e32834e1f0a
5. Aranow C. Vitamin D and the immune system. J Investig Med 2011; 59:881-6; PMID:21527855
6. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95:91-100; PMID:22170374; http://dx.doi.org/10.3945/ajcn.111.014779
7. Kamen DL, Aranow C. The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep 2008; 10:273-80; PMID:18662506; http://dx.doi.org/10.1007/s11926-008-0044-3
8. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81; PMID:17634462; http://dx.doi.org/10.1056/NEJMra070553
9. Grant WB. Solar UV-B radiation is linked to the geographic variation of mortality from systemic lupus erythematosus in the USA. Lupus 2004; 13:281-2; PMID:15176667; http://dx.doi.org/10.1191/0961203304lu522xx
10. Walsh SJ, Gilchrist A. Geographical clustering of mortality from systemic lupus erythematosus in the United States: contributions of poverty, Hispanic ethnicity and solar radiation. Lupus 2006; 15:662-70; PMID:17120593; http://dx.doi.org/10.1191/0961203306071455
11. Cooper GS, Wither J, Bernatsky S, Claudio JO, Clarke A, Rioux JD, et al. CaNIOS GenES Investigators. Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology (Oxford) 2010; 49:2172-80; PMID: 20675707; http://dx.doi.org/10.1093/rheumatology/keq214
12. Pike JW, Zella LA, Meyer MB, Fretz JA, Kim S. Molecular actions of 1,25-dihydroxyvitamin D3 on genes involved in calcium homeostasis. J Bone Miner Res 2007; 22(Suppl 2):V16-9; PMID:18290714; http://dx.doi.org/10.1359/jbmr. 07s207
13. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, et al. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009; 182:4289-95; PMID:19299728; http://dx.doi.org/10.4049/jimmunol. 0803736
14. Alvarez-Rodriguez L, Lopez-Hoyos M, Garcia-Unzueta M, Amado JA, Cacho PM, Martinez-Taboada VM. Age and low levels of circulating vitamin D are associated with impaired innate immune function; [Epub ahead of print]. J Leukoc Biol 2012; PMID:22345707; http://dx.doi.org/10.1189/jlb.1011523
15. Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 2010; 5:e9193; PMID:20169063; http://dx.doi.org/10.1371/journal.pone.0009193
16. Ritterhouse LL, Crowe SR, Niewold TB, Kamen DL, Macwana SR, Roberts VC, et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011; 70:1569-74; PMID:21586442; http://dx.doi.org/10.1136/ard.2010. 148494
17. Linker-Israeli M, Elstner E, Klinenberg JR, Wallace DJ, Koeffler HP. Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol 2001; 99:82-93; PMID:11286544; http://dx.doi.org/10.1006/clim.2000.4998
18. Mathieu C, van Etten E, Decallonne B, Guilietti A, Gysemans C, Bouillon R, et al. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 2004; 89-90:449-52; PMID:15225818; http://dx.doi.org/10.1016/j.jsbmb.2004.03.014
19. Gilkeson G, James J, Kamen D, Knackstedt T, Maggi D, Meyer A, et al. The United States to Africa lupus prevalence gradient revisited. Lupus 2011; 20:1095-103; PMID:21917913; http://dx.doi.org/10.1177/0961203311404915
20. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67:530-5; PMID: 17666449; http://dx.doi.org/10.1136/ard.2007.072736
21. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006; 5:114-7; PMID:16431339; http://dx.doi.org/10.1016/j.autrev.2005.05.009
22. Kamen DL, Alele JD. Skeletal manifestations of systemic autoimmune diseases. Curr Opin Endocrinol Diabetes Obes 2010; 17:540-5; PMID:20962632; http://dx.doi.org/10.1097/MED.0b013e328340533d
23. Malabanan AO, Holick MF. Vitamin D and bone health in postmenopausal women. J Womens Health (Larchmt) 2003; 12:151-6; PMID:12737713; http://dx.doi.org/10.1089/154099903321576547
24. Lane NE. Vitamin D and systemic lupus erythematosus: bones, muscles, and joints. Curr Rheumatol Rep 2010; 12:259-63; PMID:20429045; http://dx.doi.org/10. 1007/s11926-010-0106-1
25. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22:477-501; PMID:11493580; http://dx.doi.org/10.1210/er.22.4. 477
26. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jr., Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145:408-15; PMID:9048514; http://dx.doi.org/10.1093/oxfordjournals.aje.a009122
27. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42:338-46; PMID:10025929; http://dx.doi.org/10.1002/1529-0131(199902)42: 2〈338::AID-ANR17〉3.0.CO;2-U
28. Wu PW, Rhew EY, Dyer AR, Dunlop DD, Langman CB, Price H, et al. 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 2009; 61:1387-95; PMID:19790113; http://dx.doi.org/10.1002/art.24785
29. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44:2331-7; PMID:11665973; http://dx.doi.org/10.1002/1529-0131(200110)44: 10〈2331::AID-ART395〉3.0.CO;2-I
30. Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011; 7:399-408; PMID:21629241; http://dx.doi.org/10.1038/nrrheum.2011.75
31. Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension 2010; 55:333-8; PMID:20038753; http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.143982
32. Selzer F, Sutton-Tyrrell K, Fitzgerald S, Tracy R, Kuller L, Manzi S. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001; 37:1075-82; PMID:11304506
33. Reynolds JA, Haque S, Berry JL, Pemberton P, Teh LS, Ho P, et al. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2012; 51:544-51.
34. Sanders CJ, Van Weelden H, Kazzaz GA, Sigurdsson V, Toonstra J, Bruijnzeel-Koomen CA. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 2003; 149:131-7; PMID:12890206; http://dx.doi.org/10. 1046/j.1365-2133.2003.05379.x
35. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006; 84:694-7; PMID:17023693
36. Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 2011; 96:E447-52; PMID:21177785; http://dx.doi.org/10.1210/jc.2010-2230
37. Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 2011; 31:607-11; PMID:21378345
38. Peiris AN, Bailey BA, Guha BN, Copeland R, Manning T. Can a model predictive of vitamin D status be developed from common laboratory tests and demographic parameters? South Med J 2011; 104:636-9; PMID:21886082; http://dx.doi.org/10.1097/SMJ.0b013e3182297169
39. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 2001; 44:1496-503; PMID: 11465699; http://dx.doi.org/10.1002/1529-0131 (200107)44:7〈1496::AID-ART271〉3.0.CO;2-5
40. Kamen DL. Vitamin D in lupus - new kid on the block? Bull NYU Hosp Jt Dis 2010; 68:218-22; PMID:20969555
41. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011; 26:2341-57.
42. Marshall DT, Savage SJ, Garrett-Mayer E, Keane TE, Hollis BW, Horst RL, et al. Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab 2012; In press; PMID:22508710
43. Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008; 3:1535-41; PMID:18525006; http://dx.doi.org/10.2215/CJN.01160308
44. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77:204-10; PMID: 12499343
45. Hollis BW, Wagner CL. Assessment of dietary vitamin D requirements during pregnancy and lactation. Am J Clin Nutr 2004; 79:717-26; PMID:15113709
46. O'Regan S, Chesney RW, Hamstra A, Eisman JA, O'Gorman AM, Deluca HF. Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 1979; 68:109-11; PMID:214990; http://dx.doi.org/10.1111/j.1651-2227.1979.tb04969.x
47. Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 2001; 28:2535-9; PMID:11708429
48. Müller K, Kriegbaum NJ, Baslund B, Sørensen OH, Thymann M, Bentzen K. Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995; 14:397-400; PMID:7586974; http://dx.doi.org/10.1007/ BF02207671
49. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179:1634-47; PMID:17641030
50. Kamen DL, Barron M, Hollis BW, Oates JC, Bouali H, Bruner GR, et al. Correlation of vitamin D deficiency with lupus disease measures among Sea Island Gullah African Americans; [abstract]. Arthritis Rheum 2005; 52:S180.
51. Cutolo M, Otsa K. Review: vitamin D, immunity and lupus. Lupus 2008; 17:6-10; PMID:18089676; http://dx.doi.org/10.1177/0961203307085879
52. Wright TB, Shults J, Leonard MB, Zemel BS, Burnham JM. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009; 155:260-5; PMID:19446841; http://dx.doi.org/10.1016/j.jpeds.2009.02.033
53. Kim HA, Sung JM, Jeon JY, Yoon JM, Suh CH. Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatol Int 2011; 31:1189-94; PMID:20352222; http://dx.doi.org/10.1007/ s00296-010-1442-1
54. Hamza RT, Awwad KS, Ali MK, Hamed AI. Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit 2011; 17:CR711-8; PMID:22129903
55. Martins DC, Kang J, Kamen DL, Gilkeson GS, Aranow C, Mackay M, et al. The threshold of vitamin D required for optimal immune regulation: Implications for patients with lupus; [abstract]. Arthritis Rheum 2006; 54:S431.
56. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 2007; 1109:385-400; PMID:17785327; http://dx.doi.org/10.1196/annals.1398.044
57. Thudi A, Yin S, Wandstrat AE, Li QZ, Olsen NJ. Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. Am J Med Sci 2008; 335:99-104; PMID:18277116; http://dx.doi.org/10.1097/MAJ.0b013e318134eeb6
58. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009; 20:427-33; PMID:18600287; http://dx.doi.org/10.1007/s00198-008-0676-1
59. Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010; 69:1155-7; PMID: 20439290; http://dx.doi.org/10. 1136/ard.2009.120329
60. Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E. The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol 2011; 40:122-6; PMID: 20977384
61. Robinson AB, Thierry-Palmer M, Gibson KL, Rabinovich CE. Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis. J Pediatr 2012; 160:297-302; PMID:21924736; http://dx.doi.org/10.1016/j.jpeds.2011.08.011
62. Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A. Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 2011; 20:1155-60; PMID:21680639; http://dx.doi.org/ 10.1177/0961203311405703
63. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67:530-5; PMID:17666449; http://dx.doi.org/10.1136/ard.2007.072736
64. Toloza SM, Cole DE, Gladman DD, Ibañez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus 2010; 19:13-9; PMID:19897520; http://dx.doi.org/10.1177/0961203309345775
65. Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken) 2010; 62:1160-5; PMID:20235208; http://dx.doi.org/10.1002/acr.20186